Iceland· IS-EU/1/04/277/001-004

TachoSil

A lokale hämostatika, kombinationen product containing human fibrinogen,human thrombin, registered in Iceland by Corza Medical GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC B02BC30

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedTachoSilATCB02BC30REGISTER NO.IS-EU/1/04/277/001-004PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Lokale hämostatika, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BC30 (lokale hämostatika, kombinationen), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 7 of them publish a price we can compare per daily dose

Lokale hämostatika, kombinationen · ATC B02BC30

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Human Fibrinogen,Human thrombin
Manufacturer
Corza Medical GmbH
Country
Iceland (IS)
ATC code
B02BC30
ATC class
Lokale Hämostatika, Kombinationen
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 1

1 priced
  • ean
    095005
    1 stk x1 pakki
    ISK 53154

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lokale hämostatika, kombinationen in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lokale hämostatika, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c2df583c-8bf9-49ca-bdd9-e9a9d668e903
GET /v1/drugs/c2df583c-8bf9-49ca-bdd9-e9a9d668e903?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Vefjalímsnetja",
  "source": "lyfjastofnun",
  "atc_raw": "B02BC30",
  "marketed": true,
  "strength": null,
  "ma_number": "EU/1/04/277/001-004",
  "substance": "Human Fibrinogen,Human thrombin",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
  "ma_issued_serial": "38176"
}

See everything about lokale hämostatika, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.